Cargando…
Are the current IHS guidelines for migraine drug trials being followed?
In 2000, the Clinical Trials Subcommittee of the International Headache Society (IHS) published the second edition of its guidelines for controlled trials of drugs in migraine. The purpose of this publication was to improve the quality of such trials by increasing the awareness amongst investigators...
Autores principales: | Hougaard, Anders, Tfelt-Hansen, Peer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476229/ https://www.ncbi.nlm.nih.gov/pubmed/20931348 http://dx.doi.org/10.1007/s10194-010-0257-5 |
Ejemplares similares
-
EHMTI-0120. Are the IHS’ recommendations for evaluation and registration of adverse events in drug trials in migraine being followed ?
por: Tfelt-Hansen, P, et al.
Publicado: (2014) -
CONSORT recommendations in abstracts of randomised, controlled trials on migraine and headache
por: Tfelt-Hansen, Peer Carsten
Publicado: (2011) -
Pharmacogenomics and migraine: possible implications
por: Tfelt-Hansen, Peer, et al.
Publicado: (2008) -
Published and not fully published double-blind, randomised, controlled trials with oral naratriptan in the treatment of migraine: a review based on the GSK Trial Register
por: Tfelt-Hansen, Peer Carsten
Publicado: (2011) -
Low use of placebo in comparative drug rcts in migraine. Are clinical investigators unaware of basic methodological issues?
por: Tfelt-Hansen, PC, et al.
Publicado: (2013)